ADARB2 and glioblastoma: Owing to the known biological intersection of innate immunity, ADARs, and dsRNA, the identification of MAVS as an ADAR3-bound transcript that exhibits reduced editing in ADAR3-expressing glioblastoma cells drew our attention.